نتایج جستجو برای: oral antiviral therapy

تعداد نتایج: 900487  

Journal: :Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004
Emmet B Keeffe Douglas T Dieterich Steven-Huy B Han Ira M Jacobson Paul Martin Eugene R Schiff Hillel Tobias

Chronic HBV infection is an important public health problem worldwide and in the United States. A treatment algorithm for the management of this disease, published previously by a panel of U.S. hepatologists, has been revised on the basis of new developments in the understanding of the disorder, the availability of more sensitive molecular diagnostic tests, and the licensure of new therapies. I...

Journal: :hepatitis monthly 0
soheil tavakolpour baqiyatallah research center for gastroenterology and liver diseases, baqyiatallah university of medical sciences, tehran, ir iran seyed moayed alavian baqiyatallah research center for gastroenterology and liver diseases, baqyiatallah university of medical sciences, tehran, ir iran; baqiyatallah research center for gastroenterology and liver diseases, baqyiatallah university of medical sciences, tehran, ir iran. tel/fax: +98-2181264070 shahnaz sali infectious diseases and tropical medicine research center, shahid beheshti university of medical sciences, tehran, ir iran

results it was found that the positive hepatitis b surface antigen (hbsag), the high baseline hbv dna level, the positive hepatitis b virus e antigen (hbeag), and an absent or low hepatitis b surface antibody (hbsab) titer prior to starting treatment are the most important viral risk factors. furthermore, rituximab, anthracycline, and different types of tnf-α inhibitors were identified as the h...

Journal: :Pathogens 2023

Since May 2022, a global outbreak of human Mpox has rapidly spread in non-endemic countries. We report case 34-year-old man admitted to hospital for six-day history fever associated with vesiculo-pustular rash involving the face, limbs, trunk and perianal region, lymphadenopathy severe proctitis pharyngitis. He was HIV-positive virologically suppressed by stable antiretroviral therapy. On admis...

Journal: :Antiviral chemistry & chemotherapy 2001
K Y Hostetler R J Rybak J R Beadle M F Gardner K A Aldern K N Wright E R Kern

Human cytomegalovirus (HCMV) and herpes simplex virus (HSV) can cause a wide variety of clinical manifestations in man. Ganciclovir (GCV) is effective against HCMV infection when administered by the intravenous route and may be used orally in large doses for prophylaxis of HCMV infections in organ transplantation patients and in AIDS patients. In previous studies with acyclovir (ACV), we found ...

Journal: :medical journal of islamic republic of iran 0
g.h hakimelahi f mohanazadeh a khalafinezhad from the department of chemistry' faculty of medicine, shiraz university of medical sciences, shiraz, islamic republic of iran. m zakerinia from the department of internal medicine

the synthesis of the title compound, bitamycin, by means of bu4nf is described. this new antiviral drug was found to be one of the most powerful and least toxic substances for antiviral therapy in man. the physical and chemical behavior as well as the antiviral activities and clinical properties of this compound were found to be significantly different from that reported by schaeffer, et al. al...

2013
Hyung Joon Yim Seong Gyu Hwang

Although much advancement has been achieved in the treatment of chronic hepatitis B, antiviral resistance is still a challenging issue. Previous generation antiviral agents have already developed resistance in a number of patients, and it is still being used especially in resource limited countries. Once antiviral resistance occurs, it predisposes to subsequent resistance, resulting in multidru...

Journal: :Antiviral Therapy 2014

Journal: :Annals of hepatology 2012
Mauricio Venegas Javier Brahm Rodrigo A Villanueva

Hepatitis C virus (HCV) is an important global health problem with an estimated prevalence of more than 170 million infected individuals worldwide. Currently, the standard antiviral therapy, based on pegylated interferon alpha and ribavirin, can achieve a virological response in only nearly 50% of the patients infected with HCV genotype 1, the most widely distributed globally. During the last y...

Journal: :Visceral medicine 2016
Christoph Roderburg Frank Tacke Christian Trautwein

BACKGROUND Chronic hepatitis B and C infections represent major risk factors for the development of hepatocellular carcinoma (HCC). Recently, the management of patients with viral hepatitis has dramatically changed. In the present review we discuss the impact of these developments on the prevention of HCC as well as the treatment of patients with HCC. METHODS Studies indexed in Medline betwee...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید